AMRN: 阿玛琳

AMRN新闻

• 16:00 MRK's sBLAs for Keytruda Combo in Bladder Cancer Get FDA Priority Tag
• 15:52 BIIB Inks Deal to Acquire Rights to Felzartamab in China, Stock Up
• 15:08 Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock Up
• 12:21 Amarin将在心脏病学会议上展示REDUCE-IT亚组数据
• 12:17 Amarin to present REDUCE-IT subgroup data at cardiology meeting
• 13:24 AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know
• 14:21 Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss
• 01:02 Amarin Corporation plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:AMRN) 2026-02-25
• 10:39 New Strong Sell Stocks for January 28th
• 15:28 BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock?
• 13:34 Do Options Traders Know Something About Amarin Stock We Don't?
• 19:46 US Supreme Court to hear ’skinny label’ patent fight involving Amarin
• 16:46 AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations
• 12:09 Amarin强调VASCEPA在新型甘油三酯疗法中的作用
• 12:06 Amarin highlights VASCEPA’s role amid new triglyceride therapies
• 16:30 Why Is Vertex (VRTX) Up 2.7% Since Last Earnings Report?
• 13:38 Amarin将在美国心脏协会科学会议上展示VASCEPA新数据
• 13:37 Amarin to present new data on VASCEPA at AHA Scientific Sessions
• 16:08 Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down
• 10:26 Leerink Partners raises Amarin stock price target to $12 on strong Q3
• 14:21 Amarin Corporation plc (AMRN) Q3 2025 Earnings Call Transcript
• 12:05 FDA updates fenofibrate labels to reflect lack of cardiovascular benefit
• 14:06 Do Options Traders Know Something About Amarin Stock We Don't?
• 13:40 Are Medical Stocks Lagging Boston Scientific (BSX) This Year?